In a series of new executive orders, President Trump has taken significant steps to consolidate control over independent federal agencies, aiming to ensure that these entities align more closely with White House directives. The orders mandate that agencies such as the FTC and SEC must obtain clearance from the Administration before enacting regulations. Furthermore, Trump has introduced a policy requiring the repeal of ten existing regulations for each new one proposed, a move he claims will reduce bureaucratic red tape and stimulate economic growth. Critics warn that such aggressive deregulation could foster a risky business environment, while supporters argue it will unleash prosperity. In the health sector, questions arise about the potential impacts of these changes, particularly regarding CMS and existing regulations.